Green A, et al. Effect of ocrelizumab versus interferon β-1a on retinal thinning and association with brain volume loss in the OPERA I and OPERA II Phase III trials in relapsing multiple sclerosis. Abstract 92. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Thuis sporten met virtual reality om klachten van de ziekte van Parkinson te verlichten
nov 2019 | Bewegingsstoornissen